Activation of HIF-1α C-terminal transactivation domain promotes tubulointerstitial fibrosis through hexokinase 2-mediated metabolic reprogramming
- 28 November 2024
- journal article
- research article
- Published by Elsevier in Cellular Signalling
- Vol. 127, 111531
Abstract
No abstract availableKeywords
Funding Information
- Shandong Province Natural Science Foundation (ZR2022MH161)
- Qingdao University
- Jiangsu Province Natural Science Foundation (BK20240212)
This publication has 33 references indexed in Scilit:
- Activation of HIF-1α C-terminal transactivation domain protects against hypoxia-induced kidney injury through hexokinase 2-mediated mitophagyCell Death & Disease, 2023
- HIF1α-BNIP3-mediated mitophagy protects against renal fibrosis by decreasing ROS and inhibiting activation of the NLRP3 inflammasomeCell Death & Disease, 2023
- GPR87 promotes renal tubulointerstitial fibrosis by accelerating glycolysis and mitochondrial injuryFree Radical Biology and Medicine, 2022
- Hypoxia and chronic kidney diseaseEBioMedicine, 2022
- Hypoxia and Renal Tubulointerstitial Fibrosis2019
- Hexokinase-2 Glycolytic Overload in Diabetes and Ischemia–Reperfusion InjuryTrends in Endocrinology & Metabolism, 2019
- HIF-1α inducing exosomal microRNA-23a expression mediates the cross-talk between tubular epithelial cells and macrophages in tubulointerstitial inflammationKidney International, 2019
- Small-Molecule Modulators of the Hypoxia-Inducible Factor Pathway: Development and Therapeutic ApplicationsJournal of Medicinal Chemistry, 2019
- Renal tubule injury: a driving force toward chronic kidney diseaseKidney International, 2018
- Hypoxia-inducible factor-1α promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3Kidney International, 2016